TR200102915T2 - Etkili bir nöroleptik ilaç ihtiva eden transdermal terapötik sistem. - Google Patents

Etkili bir nöroleptik ilaç ihtiva eden transdermal terapötik sistem.

Info

Publication number
TR200102915T2
TR200102915T2 TR2001/02915T TR200102915T TR200102915T2 TR 200102915 T2 TR200102915 T2 TR 200102915T2 TR 2001/02915 T TR2001/02915 T TR 2001/02915T TR 200102915 T TR200102915 T TR 200102915T TR 200102915 T2 TR200102915 T2 TR 200102915T2
Authority
TR
Turkey
Prior art keywords
therapeutic system
system containing
transdermal therapeutic
neuroleptic drug
sensitive adhesive
Prior art date
Application number
TR2001/02915T
Other languages
English (en)
Inventor
Bracht Stefan
Horstmann Michael
Original Assignee
Lts Lohmann Therapie - Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie - Systeme Ag filed Critical Lts Lohmann Therapie - Systeme Ag
Publication of TR200102915T2 publication Critical patent/TR200102915T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Abstract

Bir destek katmani, en az bir tane etken madde ihtiva eden ana katman, ki bu katman ayni zamanda basinca duyarli yapiskan özellige de sahip olabilir, ve bir tane kaldirilabilir koruyucu katman ihtiva eden transdermal terapötik bir sistemin özelligi, bir nöroleptik bilesene, en az bir tane yayilim arttirici bilesene ve deriye temas eden bölümde saf hidrokarbon olan polimerlere dayali basinca duyarli yapiskan bir katmana sahip olmasidir.
TR2001/02915T 1999-04-22 2000-04-07 Etkili bir nöroleptik ilaç ihtiva eden transdermal terapötik sistem. TR200102915T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19918105A DE19918105C1 (de) 1999-04-22 1999-04-22 Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum

Publications (1)

Publication Number Publication Date
TR200102915T2 true TR200102915T2 (tr) 2002-01-21

Family

ID=7905367

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02915T TR200102915T2 (tr) 1999-04-22 2000-04-07 Etkili bir nöroleptik ilaç ihtiva eden transdermal terapötik sistem.

Country Status (16)

Country Link
US (1) US7560121B1 (tr)
EP (1) EP1171105B1 (tr)
JP (1) JP4163859B2 (tr)
KR (1) KR100610626B1 (tr)
CN (1) CN1194672C (tr)
AR (1) AR025521A1 (tr)
AT (1) ATE270881T1 (tr)
AU (1) AU773905B2 (tr)
BR (1) BRPI0011135B8 (tr)
CA (1) CA2370023C (tr)
DE (2) DE19918105C1 (tr)
ES (1) ES2225126T3 (tr)
MX (1) MXPA01010503A (tr)
TR (1) TR200102915T2 (tr)
WO (1) WO2000064419A1 (tr)
ZA (1) ZA200108512B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027258C1 (de) 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
DE10035891A1 (de) 2000-07-24 2002-02-14 Lohmann Therapie Syst Lts Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen
DE10110953A1 (de) * 2001-03-07 2002-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten
DE102006054732B4 (de) 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
DE102008034453A1 (de) * 2008-07-24 2010-02-11 Lts Lohmann Therapie-Systeme Ag Verfahren zum Herstellen eines Mehrschichtenverbundes auf einer CIP-fähigen Beschichtungsanlage und Verwendung des damit hergestellten Mehrschichtenverbundes für die transdermale Applikation oder die Applikation in Körperhöhlen
EP2594261A1 (en) * 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
EP3206673A1 (en) 2014-10-17 2017-08-23 Fidia Farmaceutici S.p.A. Dermal therapeutic system with high adhesivity

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
JPH01265021A (ja) * 1987-10-29 1989-10-23 Hercon Lab Corp 薬理学的活性物質を含有する組成物を動物組織に制御放出および供給するための物品
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5120545A (en) 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
DE1073432T1 (de) * 1998-04-14 2002-02-07 Gen Hospital Corp Verwendung von glycinrezeptoragonisten und glycinaufnahmeinhibitoren zur behandlung neuropsychiatrischer beschwerden

Also Published As

Publication number Publication date
AU4398600A (en) 2000-11-10
EP1171105A1 (de) 2002-01-16
DE19918105C1 (de) 2000-09-21
JP2002542278A (ja) 2002-12-10
CA2370023A1 (en) 2000-11-02
CN1348366A (zh) 2002-05-08
AR025521A1 (es) 2002-12-04
AU773905B2 (en) 2004-06-10
CA2370023C (en) 2009-06-23
BR0011135A (pt) 2003-07-29
DE50007077D1 (de) 2004-08-19
CN1194672C (zh) 2005-03-30
BRPI0011135B8 (pt) 2021-05-25
ATE270881T1 (de) 2004-07-15
MXPA01010503A (es) 2002-05-14
WO2000064419A1 (de) 2000-11-02
JP4163859B2 (ja) 2008-10-08
KR20010112453A (ko) 2001-12-20
EP1171105B1 (de) 2004-07-14
KR100610626B1 (ko) 2006-08-09
ZA200108512B (en) 2002-08-06
ES2225126T3 (es) 2005-03-16
BRPI0011135B1 (pt) 2016-09-27
US7560121B1 (en) 2009-07-14

Similar Documents

Publication Publication Date Title
BR9810700A (pt) Copolìmero em bloco
DK1014954T3 (da) Transdermalt terapeutisk system
BR9710738A (pt) Matriz para administrar medicamentos transdermalmente para co-administra-Æo de estradiol e outro esterÄide
ES2103952T3 (es) Sistemas terapeuticos transdermicos.
CY1106411T1 (el) Διαδepμικο θepαπευτικο συστημα με fentanyl
DK0973497T3 (da) Farmaceutisk bæreanordning, egnet til udlevering af farmaceutiske forbindelser til slimhindeoverflade
ES2147858T3 (es) Matriz para el suministro transdermico de farmacos.
HUP9901991A2 (hu) Transzdermális eszköz flurbiprofén átadására
MX9602656A (es) Dispositivo transdermico que contiene pirrolidona polivinilica como mejorador de solubilidad.
BRPI0510422A (pt) formulação cosmética transparente à base de microemulsões contendo um ácido alfa-hidroxicarboxìlico
DK0659081T3 (da) Dexpanthenol-holdigt plaster til transdermal applikation af steroidhormoner
TR200102915T2 (tr) Etkili bir nöroleptik ilaç ihtiva eden transdermal terapötik sistem.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
NZ595549A (en) Transdermal therapeutic system containing nicotine
DK1152751T3 (da) Transdermalt, terapeutisk desoxypeganinsysstem
HK1026362A1 (en) Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties.
TR200102581T2 (tr) Kardiovasküler hastalığın tedavisi için anjiyotensin konversiyon enzimi inhibitörünün ve epoksi-sterodial aldosteron antagonistinin kombinasyon terapisi.
HUP0204448A2 (en) Trnasdermal therapeutic system for the delivery of lerisetron
DE69700983D1 (de) Ligandgerichtete enzyme-prodrug therapie
TW200626196A (en) Microprojection array with improved skin adhesion and compliance
HUP9904181A2 (hu) Felületstabilizált gyógyszerészeti készítmény bőrön való alkalmazáshoz
WO2002038138A3 (de) Primärverpackung für transdermale therapeutische systeme oder medizinische pflaster
TR199901237T2 (tr) Bir tienilsiklohegzilamin türevinin tedavide yeni uygulamasi.
FI970702A0 (fi) Estradioli-TTS, jossa on vettä sitovia lisäaineita
TW200722107A (en) Cosmetic sheet